New hope for ulcerative colitis patients in clinical trial
NCT ID NCT07064707
Summary
This study is testing whether rupatadine, a medication, can help control ulcerative colitis symptoms and reduce inflammation. Researchers will enroll 60 adults with mild-to-moderate ulcerative colitis to evaluate safety and effectiveness. The goal is to see if this treatment can help manage this chronic bowel disease where no cure currently exists.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alexandria University
RECRUITINGAlexandria, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.